Vincent Cordero

Vincent Cordero currently serves as a Senior Commercialization Advisor at the Defense Advanced Research Projects Agency (DARPA) and is a member of the Small Business Capital Formation Advisory Committee for the U.S. Securities and Exchange Commission. Cordero is actively involved as an investor in multiple companies including Breaking, Alnair Therapeutics, Senseye, Inc., Vinco, and SOMOS, where roles include both investing and advisory capacities. Cordero's background includes co-founding Colossal Biosciences and holding an investment role at Form Bio, a spin-off of Colossal Biosciences. Additionally, Cordero has a substantial history with Mucho Mas Media as an investor and partner, along with previous positions as Co-CEO and Chief Business Officer. Academically, Cordero holds a Juris Doctor from the University of Chicago Law School, a certificate in Artificial Intelligence Implications for Business Strategy from MIT Sloan School of Management, and a Bachelor of Arts with Magna Cum Laude honors from UCLA, majoring in Philosophy, Political Science, and Chicano Studies.